Article
Structure-based grafting, mutation, and optimization of peptide inhibitors to fit in the active pocket of human secreted phospholipase A2: find new use of old Peptide agents with anti-inflammatory activity.
Chemical biology & drug design - 1 Apr 2015
Zhan Chengye, Li Shusheng, Zhong Qiang, Zhou Daixing
Abstract excerpt
Phospholipase A2 (PLA2) is a key enzyme in the production of diverse mediators of inflammatory conditions, which possesses an open active pocket that is physicochemically compatible with a variety of small-molecule substrates and peptide inhibitors. Although various peptides and peptide analogues have been identified to have inhibitory activity against PLA2 originated from animals and plants, only very few were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
